The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.
Zacks Investment Research on MSN
Organon secures FDA approval extending NEXPLANON use to five years
Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three ...
Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in ...
Medical Device Network on MSN
FDA expands use of Organon’s contraception implant up to 5 years
Organon’s Nexplanon can now be implanted for up to five years after the FDA approved a supplemental New Drug Application by ...
A Cochrane Systematic Review that set out to assess the effectiveness and tolerability of subdermal implantable contraceptives compared to other reversible methods of contraception found that they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results